TP53 and hepatocellular carcinoma: For example, simultaneous exposure to doxorubicin and paclitaxel is demonstrated to lead to the mutation of p53 and the possession of resistance in hepatocellular carcinoma (HCC) cells (Chan and Lung, 2004).